Startup profile

Kanvas Biosciences

Series APrinceton, NJ, United States$48M raised

Open roles0
Total raised$48M
Team size11-50
Founded · Stage2020 · Series A

We pull jobs from sources most job seekers never check

Email icon

Get Real-Time Job Alerts For Free

Jobs updated every minute. Get notified for free when new roles matching your interests go live.

No categories available

About the company

What they build and who they serve.

Kanvas Biosciences develops microbiome mapping technology and live biotherapeutic products. Its HiPR-Map spatial imaging platform and Spectral Lightsheet microscope let researchers locate microbes inside the gut at high resolution, feeding a pipeline of immuno-oncology and gut-restoration drug candidates that include KAN-001 for solid-tumor patients who do not respond to immune checkpoint inhibitors.

Team & contacts

Key people at the company—reach out on LinkedIn or email.

Why it matters

Signals from funding, traction, and product direction.

  • The $48M Series A brings Kanvas Biosciences' total funding to roughly $78M since inception.
  • Round was co-led by DCVC and Lions Capital, with participation from the Gates Foundation, Athos Capital, Germin8 Ventures, Ki Tua Fund and Pangaea Ventures.
  • Phase 1 clinical trial operations are already underway for KAN-004, the company's microbiome therapy targeting immune-checkpoint-inhibitor-induced colitis.
  • Stanford bioengineer Stephen Quake joined the Kanvas board ahead of the round, alongside the company's build-out of an anaerobic GMP fermentation suite in South San Francisco capable of producing multi-strain liquid-frozen live biotherapeutic products.

Funding history

Rounds and investors over time, newest first.

  1. Series A

    $48M
    Pangaea VenturesGates FoundationAthos CapitalDCVC · LeadKi Tua FundLions Capital · LeadGermin8 Ventures

In the news

Press, announcements, and coverage about this company.

Investors

Pangaea VenturesGates FoundationAthos CapitalDCVCKi Tua FundLions CapitalGermin8 Ventures

Focus areas

Series ABiotechnologyClinical TrialsHealthtech
Email alerts

Don’t get beat to tomorrow’s openings

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.

👉 Get free daily job posts